Table of Contents USA Cancer Supportive Care Medicine Market Report 2012-2023 1 Cancer Supportive Care Medicine Overview 1.1 Product Overview and Scope of Cancer Supportive Care Medicine 1.2 Classification of Cancer Supportive Care Medicine by Product Category 1.2.1 USA Cancer Supportive Care Medicine Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Cancer Supportive Care Medicine Sales (K Units) Market Share by Types in 2017 1.2.3 Antiemetic Drugs 1.2.4 Erythropoietin-Stimulating Agents 1.2.5 Granulocyte-Stimulating Agents 1.2.6 Analgesics 1.2.7 Others 1.3 USA Cancer Supportive Care Medicine Market by Application/End Users 1.3.1 USA Cancer Supportive Care Medicine (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Chemotherapy-Induced Anemia 1.3.3 CINV 1.3.4 Bone Metastasis 1.3.5 Cancer Pain 1.3.6 Other 1.4 USA Cancer Supportive Care Medicine Market by Region 1.4.1 USA Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Cancer Supportive Care Medicine (2012-2023) 1.5.1 USA Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Cancer Supportive Care Medicine 2.2 Raw Material Analysis of Cancer Supportive Care Medicine 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Cancer Supportive Care Medicine 2.4 Other Costs Analysis of Cancer Supportive Care Medicine 2.5 Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine 2.6 Manufacturing Process Analysis of Cancer Supportive Care Medicine 2.7 Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Cancer Supportive Care Medicine Players/Suppliers Profiles and Sales Data 3.1 Amgen 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Amgen Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Amgen Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 Amgen Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.2 Helsinn Healthcare 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Helsinn Healthcare Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 Helsinn Healthcare Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.3 Johnson &Johnson 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Johnson &Johnson Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Johnson &Johnson Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 Johnson &Johnson Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.4 Merck 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Merck Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Merck Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 Merck Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.5 F. Hoffmann-La Roche 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 F. Hoffmann-La Roche Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.6 GlaxoSmithKline 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 GlaxoSmithKline Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 GlaxoSmithKline Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.7 Heron Therapeutics 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Heron Therapeutics Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Heron Therapeutics Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 Heron Therapeutics Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.8 Kyowa Hakko Kirin 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Kyowa Hakko Kirin Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.9 Novartis 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Novartis Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Novartis Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 Novartis Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.10 TESARO 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 TESARO Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 TESARO Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 TESARO Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.11 Teva Pharmaceutical Industries 4 USA Cancer Supportive Care Medicine Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Cancer Supportive Care Medicine Market Competition by Players/Manufacturers 4.1.1 USA Cancer Supportive Care Medicine Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Cancer Supportive Care Medicine Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Cancer Supportive Care Medicine Sales and Revenue by Type 4.2.1 USA Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Cancer Supportive Care Medicine Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Cancer Supportive Care Medicine Sales and Revenue by Application 4.3.1 USA Cancer Supportive Care Medicine Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Cancer Supportive Care Medicine Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Cancer Supportive Care Medicine Sales (K Units) by Application 5 Northeast Cancer Supportive Care Medicine (Sales, Revenue and Price) 5.1 Northeast Cancer Supportive Care Medicine Sales and Value (2012-2017) 5.1.1 Northeast Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 5.3 Northeast Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 6 Midwest Cancer Supportive Care Medicine (Sales, Revenue and Price) 6.1 Midwest Cancer Supportive Care Medicine Sales and Value (2012-2017) 6.1.1 Midwest Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 6.3 Midwest Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 7 South Cancer Supportive Care Medicine (Sales, Revenue and Price) 7.1 South Cancer Supportive Care Medicine Sales and Value (2012-2017) 7.1.1 South Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 7.1.3 South Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 7.3 South Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 8 West Cancer Supportive Care Medicine (Sales, Revenue and Price) 8.1 West Cancer Supportive Care Medicine Sales and Value (2012-2017) 8.1.1 West Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 8.1.3 West Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 8.3 West Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Cancer Supportive Care Medicine Market Forecast (2018-2023) 12.1 USA Cancer Supportive Care Medicine Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Cancer Supportive Care Medicine Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Cancer Supportive Care Medicine Price and Trend Forecast (2018-2023) 12.2 USA Cancer Supportive Care Medicine Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Cancer Supportive Care Medicine Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Cancer Supportive Care Medicine Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Cancer Supportive Care Medicine Sales Forecast by Type (2018-2023) 12.3.2 USA Cancer Supportive Care Medicine Revenue Forecast by Type (2018-2023) 12.3.3 USA Cancer Supportive Care Medicine Price Forecast by Type (2018-2023) 12.4 USA Cancer Supportive Care Medicine Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Cancer Supportive Care Medicine Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Cancer Supportive Care Medicine Sales (K Units) by Application (2016-2023) Figure Product Picture of Cancer Supportive Care Medicine Table USA Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Cancer Supportive Care Medicine Sales (K Units) Market Share by Types in 2017 Figure Antiemetic Drugs Picture Figure Erythropoietin-Stimulating Agents Picture Figure Granulocyte-Stimulating Agents Picture Table USA Cancer Supportive Care Medicine Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Cancer Supportive Care Medicine by Applications in 2017 Figure Chemotherapy-Induced Anemia Examples Figure CINV Examples Figure Bone Metastasis Examples Table USA Market Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure South Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure West Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2023) Figure USA Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Cancer Supportive Care Medicine Table Industry News List of Cancer Supportive Care Medicine Figure Industry Chain Structure of Cancer Supportive Care Medicine Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine in 2017 Figure Manufacturing Process Analysis of Cancer Supportive Care Medicine Table Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2017 Table Major Buyers of Cancer Supportive Care Medicine Table Amgen Basic Information List Table Amgen Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Amgen Cancer Supportive Care Medicine Sales USA Market Share (%) (2012-2017) Figure Amgen Cancer Supportive Care Medicine Revenue USA Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amgen Cancer Supportive Care Medicine Volume in and Its Application Share Table Amgen Cancer Supportive Care Medicine Volume in and Its Application Share Table Amgen Cancer Supportive Care Medicine Volume in and Its Application Share Table Helsinn Healthcare Basic Information List Table Helsinn Healthcare Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Sales USA Market Share (%) (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Revenue USA Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in and Its Application Share Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in and Its Application Share Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in and Its Application Share Table Johnson &Johnson Basic Information List Table Johnson &Johnson Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Sales USA Market Share (%) (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Revenue USA Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson &Johnson Cancer Supportive Care Medicine Volume in and Its Application Share Table Johnson &Johnson Cancer Supportive Care Medicine Volume in and Its Application Share Table Johnson &Johnson Cancer Supportive Care Medicine Volume in and Its Application Share Table Merck Basic Information List Table Merck Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Merck Cancer Supportive Care Medicine Sales USA Market Share (%) (2012-2017) Figure Merck Cancer Supportive Care Medicine Revenue USA Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck Cancer Supportive Care Medicine Volume in and Its Application Share Table Merck Cancer Supportive Care Medicine Volume in and Its Application Share Table Merck Cancer Supportive Care Medicine Volume in and Its Application Share Table F. Hoffmann-La Roche Basic Information List Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales USA Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Revenue USA Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in and Its Application Share Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in and Its Application Share Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Sales USA Market Share (%) (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Revenue USA Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in and Its Application Share Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in and Its Application Share Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in and Its Application Share Table Heron Therapeutics Basic Information List Table Heron Therapeutics Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Sales USA Market Share (%) (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Revenue USA Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Heron Therapeutics Cancer Supportive Care Medicine Volume in and Its Application Share Table Heron Therapeutics Cancer Supportive Care Medicine Volume in and Its Application Share Table Heron Therapeutics Cancer Supportive Care Medicine Volume in and Its Application Share Table Kyowa Hakko Kirin Basic Information List Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales USA Market Share (%) (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Revenue USA Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in and Its Application Share Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in and Its Application Share Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in and Its Application Share Table Novartis Basic Information List Table Novartis Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Novartis Cancer Supportive Care Medicine Sales USA Market Share (%) (2012-2017) Figure Novartis Cancer Supportive Care Medicine Revenue USA Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis Cancer Supportive Care Medicine Volume in and Its Application Share Table Novartis Cancer Supportive Care Medicine Volume in and Its Application Share Table Novartis Cancer Supportive Care Medicine Volume in and Its Application Share Table Company TESARO Basic Information List Table Company TESARO Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company TESARO Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Company TESARO Cancer Supportive Care Medicine Sales USA Market Share (%) (2012-2017) Figure Company TESARO Cancer Supportive Care Medicine Revenue USA Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company TESARO Cancer Supportive Care Medicine Volume in and Its Application Share Table Company TESARO Cancer Supportive Care Medicine Volume in and Its Application Share Table Company TESARO Cancer Supportive Care Medicine Volume in and Its Application Share Table USA Cancer Supportive Care Medicine Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Cancer Supportive Care Medicine Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Cancer Supportive Care Medicine Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Cancer Supportive Care Medicine Sales Share by Players/Manufacturers Table USA Cancer Supportive Care Medicine Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Cancer Supportive Care Medicine Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Cancer Supportive Care Medicine Revenue Market Share (%) Players Figure 2017 USA Cancer Supportive Care Medicine Revenue Market Share (%) Players Table USA Cancer Supportive Care Medicine Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Cancer Supportive Care Medicine Sales Share by Type (2012-2017) Figure Sales Market Share of Cancer Supportive Care Medicine by Type (2012-2017) Figure USA Cancer Supportive Care Medicine Sales Growth Rate (%) by Type (2012-2017) Table USA Cancer Supportive Care Medicine Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Cancer Supportive Care Medicine Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Cancer Supportive Care Medicine by Type (2012-2017) Figure USA Cancer Supportive Care Medicine Revenue Growth Rate by Type (2012-2017) Table USA Cancer Supportive Care Medicine Sales (K Units) and Market Share by Regions (2012-2017) Table USA Cancer Supportive Care Medicine Sales Share by Regions (2012-2017) Figure Sales Market Share of Cancer Supportive Care Medicine by Regions (2012-2017) Figure USA Cancer Supportive Care Medicine Sales Market Share by Regions in 2017 Table USA Cancer Supportive Care Medicine Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Cancer Supportive Care Medicine Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Cancer Supportive Care Medicine by Regions (2012-2017) Figure USA Cancer Supportive Care Medicine Revenue Market Share by Regions in 2017 Table USA Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application (2012-2017) Table USA Cancer Supportive Care Medicine Sales Share (%) by Application (2012-2017) Figure USA Cancer Supportive Care Medicine Sales Market Share by Application (2012-2017) Figure USA Cancer Supportive Care Medicine Sales Market Share by Application (2012-2017) Figure Northeast Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table Northeast Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table Northeast Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table Northeast Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure Midwest Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table Midwest Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table Midwest Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table Midwest Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure South Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure South Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table South Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table South Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure South Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table South Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table South Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure South Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure West Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure West Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table West Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table West Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure West Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table West Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table West Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure West Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Cancer Supportive Care Medicine Price and Trend Forecast (2018-2023) Table USA Cancer Supportive Care Medicine Sales (K Units) Forecast by Regions (2018-2023) Figure USA Cancer Supportive Care Medicine Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Cancer Supportive Care Medicine Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Cancer Supportive Care Medicine Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Cancer Supportive Care Medicine Revenue Market Share Forecast by Regions (2018-2023) Figure USA Cancer Supportive Care Medicine Revenue Market Share Forecast by Regions in 2023 Figure Northeast Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Cancer Supportive Care Medicine Sales (K Units) Forecast by Type (2018-2023) Figure USA Cancer Supportive Care Medicine Sales Market Share Forecast by Type (2018-2023) Table USA Cancer Supportive Care Medicine Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Cancer Supportive Care Medicine Revenue Market Share Forecast by Type (2018-2023) Table USA Cancer Supportive Care Medicine Price (USD/Unit) Forecast by Type (2018-2023) Table USA Cancer Supportive Care Medicine Sales (K Units) Forecast by Application (2018-2023) Figure USA Cancer Supportive Care Medicine Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Amgen Helsinn Healthcare Johnson &Johnson Merck F. Hoffmann-La Roche GlaxoSmithKline Heron Therapeutics Kyowa Hakko Kirin Novartis TESARO Teva Pharmaceutical Industries